Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.7127 per EA under NDC 70710100802. Its NADAC has been published 481 times since Apr 12, 2017.
Strength
30 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710100802
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA208578On Market Since
2/24/2017
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 481 times since Apr 12, 2017, and over the history we have for it it has declined 91.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7127 per EA |
|---|---|
| All-time high | $8.7338 (May 10, 2017) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $2.2425 |
| Average price | $3.3106 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 481 |
| Tracking since | Apr 12, 2017 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.7127 per EA (NDC 70710100802), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 91.6%. It has been tracked across 481 weekly CMS publications since Apr 12, 2017.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Apr 12, 2017, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $8.7338 (May 10, 2017), with a median of $2.2425 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as OSELTAMIVIR PHOS 30 MG CAPSULE, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 70710100802) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification